Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Major Depressive Disorder · Migraine · AXSM

Axsome Therapeutics

Axsome Therapeutics patent portfolio — 162 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
One World Trade Center, New York, NY 10007, US HQ
2012 Founded
981 Employees
Public company Type
AXSM · NYSE Ticker
Company details
Status
Public
HQ
One World Trade Center, New York, NY 10007, US
Founded
2012
Employees
981
Programs
28
Drugs
12
Patents
162
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Axsome Therapeutics patents

162 pharmaceutical patents indexed for Axsome Therapeutics. 0 expire within 24 months.

Axsome Therapeutics has 162 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

162 patents

Patent portfolio

Page 3 of 4

  1. US 11129895

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11129826

    Bupropion as a modulator of drug activity

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11123344

    Bupropion as a modulator of drug activity

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11123431

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11110173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11077117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11045549

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11020402

    Use of reboxetine to treat narcolepsy

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11020483

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11013805

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11013806

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10987358

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10940153

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10933136

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10933137

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10918722

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10905693

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10894053

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10821181

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10821182

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10799588

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10780165

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10780166

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10758617

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10758618

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10729697

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10729774

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10729696

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10729773

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10722583

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10702602

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10702535

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10695429

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10695304

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10695430

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10688185

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10688102

    Combination treatment for migraine and other pain

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10653777

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10583144

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10583088

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10561664

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10537642

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10532101

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10517950

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10512692

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10512693

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10485871

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10471069

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

162 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.